In an article for CNN.com, the infamous Dr. Sanjay Gupta shared his thoughts in a letter addressed to United States Attorney General Jeff Sessions on medical marijuana and how the consumption of the plant can be effective in the treating opioid addicts.
Research from the Rand Corp. found that there was a 20% decline in opioid based deaths in the U.S. states that have legalized medicinal marijuana from 1999 to 2010. Gupta goes on to state that cannabis can help struggling addicts. Based on his research he has found that it has been effective in treating pain associated with withdrawal symptoms, which is one of the biggest reasons those addicted to opioids choose not to gain their sobriety.
Gupta’s research found that those addicted to synthetic opioids for extended periods of time have fundamentally changed their brains chemistry. This is why “going cold-turkey” has such a low percentage of success.
Yasmin Hurd, Director of the Addiction Institute at Mount Sinai New York, has found that the non-psychoactive chemical CBD, or Cannabidiol, that is found in the cannabis and industrial hemp plant can help addicts restore their normal brain function.
Dr. Gupta goes on to invite the Attorney General Jeff Sessions, who has been very outspoken on his negative opinion on the medical benefits of cannabis, to visit the numerous clinics with established research involved with addicts and cannabis around the country.
“Recently, your fellow conservative John Boehner changed his mind after being “unalterably opposed” to marijuana in the past. If you do the same, Mr. Attorney General, thousands of lives could be improved and saved. There is no time to lose.”
You may be interested
MJardin Group Announces CSE Listing and GrowForce AcquisitionEditor - November 16, 2018
MJardin Group, Inc. (CSE: MJAR) announced earlier this week that the company will begin trading the company’s common stock on the Canadian Securities Exchange, under the ticket…
Invictus Strategies Corp. to Acquire GTEC Holdings in Exchange for $100M in StockEditor - November 16, 2018
Invictus Strategies Corp. (TSXV: GENE) (OTCQX: IVITF) has announced this morning that the company has entered into an agreement to acquire GTEC Holdings Ltd. (TSXV: GTEC) (OTC:…
Columbia Care Receives Licenses from Maltese GovernmentEditor - November 15, 2018
Columbia Care LLC. has announced this morning that the company has gain approval from Malta Enterprises, the regulatory economic development agency in the country, to receive licenses…